CARISSA SMITH: Open Payments
NPI 1568072817 · ROCKY MOUNT, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$309 in 18 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $431 · 2025 $309
Food & beverage: $309
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $93 |
| ABBVIE INC. | 3 | $59 |
| Amgen Inc. | 3 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Novo Nordisk Inc | 1 | $22 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: FARXIGA, OTEZLA, VRAYLAR, Kerendia, XIFAXAN, Ozempic, CONTRAVE, TRELEGY ELLIPTA.
Industry payments across NC — which companies pay providers there.
